Ticker News
$HCTI News
Stored TradersLink news articles and press-release context for this ticker. Discord alerts link into these article pages when full article text is available.
Published Articles
Latest saved alerts
HCTI agrees to issue 2.83M shares as make‑whole; multiple preferred issues convertible after shareholder approval
HEALTHCARE TRIANGLE, INC. filed SEC Form 8-K. Healthcare Triangle agreed to issue 2,828,167 common shares to SecureKloud as a make‑whole, but that issuance is conditioned on stockholder approval under Nasdaq Rule 5635(b) and will be included in the company's next resale registration (so not immediately tradeable). An amendment also provides for $12,000,000 of restricted common stock and issuance of 18,000 preferred shares (issued June 26, 2026 but not convertible until shareholder approval), with any excess over 19.99% delivered as pre‑funded warrants exercisable only after approval. The company filed a Certificate designating 23,000 shares of Series C convertible preferred (convertible at the company's option into ~9.9M common shares after shareholder approval), so there is significant potential post‑approval dilution if conversions/exercises occur.
HCTI closes ~$3.6M private placement of 15% OID senior convertible notes; conversion earliest in six months
Healthcare Triangle (HCTI) closed a private placement of 15% original-issue-discount senior convertible promissory notes with aggregate principal of $4.235M for gross proceeds of approximately $3.6M (before fees). The notes mature Dec 12, 2026 and are convertible at the holder's option any time after the six-month anniversary at a conversion price equal to 85% of the 3‑day VWAP, so equity dilution is delayed until conversions can begin (earliest ~Dec 12, 2026). Timing: Warrant exercises are already completed, so dilution is already in effect.
HCTI closes ~$3.6M private placement of 15% OID senior convertible notes
Healthcare Triangle closed a private placement of 15% original-issue-discount senior convertible promissory notes, raising approximately $3.6M in gross proceeds (aggregate principal $4.235M). The notes mature Dec 12, 2026 and are convertible at the holder's option any time after the six-month anniversary (starting 2026-12-12) at a conversion price equal to 85% of the 3-day VWAP prior to conversion notice; WallachBeth Capital was placement agent. Timing: Warrant exercises are already completed, so dilution is already in effect.
